| OASIS-3: Longitudinal neuroimaging, clinical, and cognitive dataset for normal aging and Alzheimer disease PJ LaMontagne, TLS Benzinger, JC Morris, S Keefe, R Hornbeck, ... MedRxiv, 2019 | 790 | 2019 |
| Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers BA Gordon, TM Blazey, J Christensen, A Dincer, S Flores, S Keefe, ... Brain 142 (4), 1063-1076, 2019 | 166 | 2019 |
| A Web-based archive of systematic review data S Ip, N Hadar, S Keefe, C Parkin, R Iovin, EM Balk, J Lau Systematic reviews 1, 1-7, 2012 | 84 | 2012 |
| Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease SA Schultz, JF Strain, A Adedokun, Q Wang, O Preische, J Kuhle, S Flores, ... Neurobiology of disease 142, 104960, 2020 | 52 | 2020 |
| Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia LN Koenig, GS Day, A Salter, S Keefe, LM Marple, J Long, P LaMontagne, ... NeuroImage: Clinical 26, 102248, 2020 | 50 | 2020 |
| Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease A Dincer, BA Gordon, A Hari-Raj, SJ Keefe, S Flores, NS McKay, ... NeuroImage: Clinical 28, 102491, 2020 | 28 | 2020 |
| OASIS-3: Longitudinal neuroimaging, clinical, and cognitive dataset for normal aging and Alzheimer disease PJ LaMontagne, S Keefe, W Lauren, C Xiong, EA Grant, KL Moulder, ... Alzheimer's & Dementia 14 (7S_Part_2), P138-P138, 2018 | 24 | 2018 |
| Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN) NS McKay, BA Gordon, RC Hornbeck, A Dincer, S Flores, SJ Keefe, ... Nature neuroscience 26 (8), 1449-1460, 2023 | 23 | 2023 |
| APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression A Dincer, CD Chen, NS McKay, LN Koenig, A McCullough, S Flores, ... Science translational medicine 14 (671), eabl7646, 2022 | 21 | 2022 |
| Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease L Vermunt, E Dicks, G Wang, A Dincer, S Flores, SJ Keefe, SB Berman, ... Brain communications 2 (2), fcaa102, 2020 | 17 | 2020 |
| Investigating Tau and amyloid tracer skull binding in studies of Alzheimer disease S Flores, CD Chen, Y Su, A Dincer, SJ Keefe, NS McKay, AM Paulick, ... Journal of Nuclear Medicine 64 (2), 287-293, 2023 | 15 | 2023 |
| Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial O Wagemann, H Liu, G Wang, X Shi, T Bittner, MA Scelsi, MR Farlow, ... JAMA neurology, 2024 | 13 | 2024 |
| Sex-specific patterns of body mass index relationship with white matter connectivity F Rahmani, Q Wang, NS McKay, S Keefe, N Hantler, R Hornbeck, Y Wang, ... Journal of Alzheimer's Disease 86 (4), 1831-1848, 2022 | 13 | 2022 |
| Neuroimaging within the dominantly inherited Alzheimer’s network (DIAN): PET and MRI NS McKay, BA Gordon, RC Hornbeck, CR Jack, R Koeppe, S Flores, ... BioRxiv, 2022.03. 25.485799, 2022 | 10 | 2022 |
| Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer’s disease KL Meeker, PH Luckett, NR Barthélemy, DA Hobbs, C Chen, J Bollinger, ... Brain Communications 6 (2), fcae081, 2024 | 9 | 2024 |
| Relationships of cognitive measures with cerebrospinal fluid but not imaging biomarkers of Alzheimer disease vary between Black and white individuals S Bonomi, R Lu, SE Schindler, Q Bui, JJ Lah, D Wolk, CE Gleason, ... Annals of neurology 95 (3), 495-506, 2023 | 9 | 2023 |
| γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited … SA Schultz, L Liu, AP Schultz, CD Fitzpatrick, R Levin, JP Bellier, ... The Lancet Neurology 23 (9), 913-924, 2024 | 8 | 2024 |
| CSF proteomics identifies early changes in autosomal dominant Alzheimer’s disease Y Shen, J Timsina, G Heo, A Beric, M Ali, C Wang, C Yang, Y Wang, ... Cell 187 (22), 6309-6326. e15, 2024 | 4 | 2024 |
| Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients MR Brier, SE Schindler, A Salter, D Perantie, N Shelley, B Judge, S Keefe, ... Annals of neurology 96 (3), 453-459, 2024 | 4 | 2024 |
| Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging S Doering, A McCullough, BA Gordon, CD Chen, N McKay, D Hobbs, ... EBioMedicine 103, 2024 | 4 | 2024 |
